These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 33228711)
1. Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma. Kunz M; Brandl M; Bhattacharya A; Nobereit-Siegel L; Ewe A; Weirauch U; Hering D; Reinert A; Kalwa H; Guzman J; Weigelt K; Wach S; Taubert H; Aigner A J Nanobiotechnology; 2020 Nov; 18(1):173. PubMed ID: 33228711 [TBL] [Abstract][Full Text] [Related]
2. Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA delivery in vitro and in vivo. Zhupanyn P; Ewe A; Büch T; Malek A; Rademacher P; Müller C; Reinert A; Jaimes Y; Aigner A J Control Release; 2020 Mar; 319():63-76. PubMed ID: 31866504 [TBL] [Abstract][Full Text] [Related]
3. PEI-complexed LNA antiseeds as miRNA inhibitors. Thomas M; Lange-Grünweller K; Dayyoub E; Bakowsky U; Weirauch U; Aigner A; Hartmann RK; Grünweller A RNA Biol; 2012 Aug; 9(8):1088-98. PubMed ID: 22894918 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. Ibrahim AF; Weirauch U; Thomas M; Grünweller A; Hartmann RK; Aigner A Cancer Res; 2011 Aug; 71(15):5214-24. PubMed ID: 21690566 [TBL] [Abstract][Full Text] [Related]
5. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab. Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738 [TBL] [Abstract][Full Text] [Related]
6. miRNA oligonucleotide and sponge for miRNA-21 inhibition mediated by PEI-PLL in breast cancer therapy. Gao S; Tian H; Guo Y; Li Y; Guo Z; Zhu X; Chen X Acta Biomater; 2015 Oct; 25():184-93. PubMed ID: 26169933 [TBL] [Abstract][Full Text] [Related]
7. Cationic microRNA-delivering nanocarriers for efficient treatment of colon carcinoma in xenograft model. Liang G; Zhu Y; Jing A; Wang J; Hu F; Feng W; Xiao Z; Chen B Gene Ther; 2016 Dec; 23(12):829-838. PubMed ID: 27482839 [TBL] [Abstract][Full Text] [Related]
8. Self-assembled dual fluorescence nanoparticles for CD44-targeted delivery of anti-miR-27a in liver cancer theranostics. Zheng X; Zhang F; Zhao Y; Zhang J; Dawulieti J; Pan Y; Cui L; Sun M; Shao D; Li M; He K; Zhang M; Li J; Chen L Theranostics; 2018; 8(14):3808-3823. PubMed ID: 30083261 [TBL] [Abstract][Full Text] [Related]
9. Optimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model. Ewe A; Höbel S; Heine C; Merz L; Kallendrusch S; Bechmann I; Merz F; Franke H; Aigner A Drug Deliv Transl Res; 2017 Apr; 7(2):206-216. PubMed ID: 27334279 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA silencing for cancer therapy targeted to the tumour microenvironment. Cheng CJ; Bahal R; Babar IA; Pincus Z; Barrera F; Liu C; Svoronos A; Braddock DT; Glazer PM; Engelman DM; Saltzman WM; Slack FJ Nature; 2015 Feb; 518(7537):107-10. PubMed ID: 25409146 [TBL] [Abstract][Full Text] [Related]
11. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes. Werth S; Urban-Klein B; Dai L; Höbel S; Grzelinski M; Bakowsky U; Czubayko F; Aigner A J Control Release; 2006 May; 112(2):257-70. PubMed ID: 16574264 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Bernardo BC; Gao XM; Winbanks CE; Boey EJ; Tham YK; Kiriazis H; Gregorevic P; Obad S; Kauppinen S; Du XJ; Lin RC; McMullen JR Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17615-20. PubMed ID: 23047694 [TBL] [Abstract][Full Text] [Related]
13. Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension. McLendon JM; Joshi SR; Sparks J; Matar M; Fewell JG; Abe K; Oka M; McMurtry IF; Gerthoffer WT J Control Release; 2015 Jul; 210():67-75. PubMed ID: 25979327 [TBL] [Abstract][Full Text] [Related]
14. A novel MUC1 aptamer-modified PLGA-epirubicin-PβAE-antimir-21 nanocomplex platform for targeted co-delivery of anticancer agents in vitro and in vivo. Bahreyni A; Alibolandi M; Ramezani M; Sarafan Sadeghi A; Abnous K; Taghdisi SM Colloids Surf B Biointerfaces; 2019 Mar; 175():231-238. PubMed ID: 30537619 [TBL] [Abstract][Full Text] [Related]
15. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts. Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274 [TBL] [Abstract][Full Text] [Related]
16. Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery. Höbel S; Prinz R; Malek A; Urban-Klein B; Sitterberg J; Bakowsky U; Czubayko F; Aigner A Eur J Pharm Biopharm; 2008 Sep; 70(1):29-41. PubMed ID: 18499413 [TBL] [Abstract][Full Text] [Related]
17. Cationic Polymer Nanoparticles-Mediated Delivery of miR-124 Impairs Tumorigenicity of Prostate Cancer Cells. Conte R; Valentino A; Di Cristo F; Peluso G; Cerruti P; Di Salle A; Calarco A Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013257 [TBL] [Abstract][Full Text] [Related]
18. New tumor-targeted nanosized delivery carrier for oligonucleotides: characteristics in vitro and in vivo. Zhou T; Jia X; Li H; Wang J; Zhang H; A Y; Zhang Z Int J Nanomedicine; 2011; 6():1527-34. PubMed ID: 21845042 [TBL] [Abstract][Full Text] [Related]
19. Lipid Nanoparticles Composed of Quaternary Amine-Tertiary Amine Cationic Lipid Combination (QTsome) for Therapeutic Delivery of AntimiR-21 for Lung Cancer. Yung BC; Li J; Zhang M; Cheng X; Li H; Yung EM; Kang C; Cosby LE; Liu Y; Teng L; Lee RJ Mol Pharm; 2016 Feb; 13(2):653-62. PubMed ID: 26741162 [TBL] [Abstract][Full Text] [Related]
20. Simultaneous Targeting of Multiple oncomiRs with Phosphorothioate or PNA-Based Anti-miRs in Lymphoma Cell Lines. Dhuri K; Pradeep SP; Shi J; Anastasiadou E; Slack FJ; Gupta A; Zhong XB; Bahal R Pharm Res; 2022 Nov; 39(11):2709-2720. PubMed ID: 36071352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]